Fresenius Medical Care AG & Co. KGaA (FME) PT Set at €97.90 by JPMorgan Chase & Co.

Share on StockTwits

JPMorgan Chase & Co. set a €97.90 ($113.84) price objective on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a report published on Wednesday morning. The firm currently has a buy rating on the stock.

A number of other equities research analysts have also recently weighed in on the company. Commerzbank set a €80.00 ($93.02) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a report on Wednesday. Goldman Sachs Group set a €98.00 ($113.95) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Wednesday. Sanford C. Bernstein set a €107.00 ($124.42) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Wednesday. Berenberg Bank set a €100.80 ($117.21) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Wednesday. Finally, Deutsche Bank set a €107.00 ($124.42) price target on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a report on Friday, October 5th. Nine equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The company has a consensus rating of Buy and a consensus price target of €92.77 ($107.87).

FME opened at €70.10 ($81.51) on Wednesday. Fresenius Medical Care AG & Co. KGaA has a 1-year low of €75.53 ($87.83) and a 1-year high of €93.82 ($109.09).

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

See Also: What is dollar cost averaging (DCA)?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Mitek Systems  Downgraded by BidaskClub to Hold
Mitek Systems Downgraded by BidaskClub to Hold
Fred J. Dyment Purchases 25,000 Shares of ARC Resources Ltd  Stock
Fred J. Dyment Purchases 25,000 Shares of ARC Resources Ltd Stock
Capital International Sarl Decreases Holdings in Enbridge Inc
Capital International Sarl Decreases Holdings in Enbridge Inc
Comparing Naked Brand Group  & VF
Comparing Naked Brand Group & VF
Silence Therapeutics   Shares Down 15.1%
Silence Therapeutics Shares Down 15.1%
Zacks: Analysts Anticipate Mongodb Inc  Will Post Earnings of -$0.38 Per Share
Zacks: Analysts Anticipate Mongodb Inc Will Post Earnings of -$0.38 Per Share


© 2006-2018 Ticker Report